Home ›
NPI 1437195260
NPI deactivated
1437195260
1437195260 was paid $341K by Medicaid between Jan 2018 and Sep 2024, across 57 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 82% of everything it billed.
33Billing provider info1437195260
33aNPI1437195260
33bProvider type—
28Total paid$341K
24GClaims30,138
24DCodes billed57
24AFirst – last monthJan 2018 – Sep 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,541 | $2K | |
| 2019 | 8,747 | $42K | |
| 2020 | 4,296 | $138K | |
| 2021 | 4,114 | $156K | |
| 2022 | 1,537 | $1K | |
| 2023 | 629 | $536.57 | |
| 2024incomplete | 274 | $262.16 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 82% | 5,092 | 4,833 | $281K |
| 80053 | Comprehensive metabolic panel | 2.0% | 3,236 | 3,178 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 2,067 | 2,057 | $7K |
| 80061 | Lipid panel | 1.9% | 2,584 | 2,573 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 3,268 | 3,203 | $6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.4% | 136 | 128 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 1,809 | 1,798 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 688 | 671 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 698 | 681 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 612 | 610 | $3K |
| 83655 | <1% | 699 | 698 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 454 | 451 | $2K |
45 more codes
| 86003 | <1% | 13 | $1K | |
| 86592 | <1% | 1,302 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 31 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 180 | $828.37 |
| 81001 | <1% | 1,249 | $827.77 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 433 | $476.50 |
| 84436 | <1% | 250 | $402.24 | |
| 84153 | <1% | 65 | $378.01 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 106 | $360.45 |
| 82043 | <1% | 259 | $318.27 | |
| 87070 | <1% | 271 | $309.33 | |
| 82570 | <1% | 269 | $307.72 | |
| 84439 | <1% | 205 | $306.73 | |
| 82248 | <1% | 246 | $285.57 | |
| 85027 | <1% | 269 | $269.16 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 39 | $265.93 |
| 87088 | <1% | 233 | $242.06 | |
| 82785 | <1% | 14 | $187.85 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,373 | $157.62 |
| 87254 | <1% | 23 | $118.01 | |
| 85652 | <1% | 140 | $79.08 | |
| 81003 | <1% | 137 | $62.33 | |
| 84550 | <1% | 87 | $52.01 | |
| 86140 | <1% | 76 | $45.80 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 12 | $0.00 |
| 86803 | 0% | 12 | $0.00 | |
| 80349 | 0% | 20 | $0.00 | |
| 85730 | 0% | 12 | $0.00 | |
| 82728 | 0% | 28 | $0.00 | |
| 87147 | 0% | 13 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 13 | $0.00 |
| 87340 | 0% | 29 | $0.00 | |
| 87077 | 0% | 19 | $0.00 | |
| 83550 | 0% | 13 | $0.00 | |
| 86038 | 0% | 55 | $0.00 | |
| 86431 | 0% | 38 | $0.00 | |
| 80365 | 0% | 28 | $0.00 | |
| 99001 | 0% | 99 | $0.00 | |
| 87186 | 0% | 32 | $0.00 | |
| 82274 | 0% | 20 | $0.00 | |
| 85610 | 0% | 17 | $0.00 | |
| 80361 | 0% | 28 | $0.00 | |
| 83540 | 0% | 12 | $0.00 | |
| 80074 | 0% | 13 | $0.00 | |
| 84481 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.